In the past week, SBRA stock has gone down by -3.54%, with a monthly gain of 8.00% and a quarterly surge of 2.51%. The volatility ratio for the week is 1.73%, and the volatility levels for the last 30 days are 2.50% for Sabra Healthcare REIT Inc The simple moving average for the last 20 days is 0.78% for SBRA’s stock, with a simple moving average of 0.40% for the last 200 days.
Is It Worth Investing in Sabra Healthcare REIT Inc (NASDAQ: SBRA) Right Now?
The price-to-earnings ratio for Sabra Healthcare REIT Inc (NASDAQ: SBRA) is 32.02x, which is above its average ratio. Moreover, the 36-month beta value for SBRA is 0.94. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 1 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for SBRA is 233.61M and currently, short sellers hold a 7.30% of that float. On March 26, 2025, SBRA’s average trading volume was 2.22M shares.
SBRA) stock’s latest price update
Sabra Healthcare REIT Inc (NASDAQ: SBRA) has experienced a decline in its stock price by -1.15 compared to its previous closing price of 17.35. However, the company has seen a fall of -3.54% in its stock price over the last five trading days. businesswire.com reported 2025-03-24 that TUSTIN, Calif.–(BUSINESS WIRE)—- $CIO #CIO–Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra’s Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra’s Executive Vice President, Investments, is expected to be elevated to the role of Sabra’s Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.
Analysts’ Opinion of SBRA
JMP Securities, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $20. The rating they have provided for SBRA stocks is “Mkt Outperform” according to the report published on January 07th, 2025.
Mizuho gave a rating of “Neutral” to SBRA, setting the target price at $20 in the report published on December 05th of the previous year.
SBRA Trading at 2.03% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.21% of loss for the given period.
Volatility was left at 2.50%, however, over the last 30 days, the volatility rate increased by 1.73%, as shares surge +4.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.38% upper at present.
During the last 5 trading sessions, SBRA fell by -3.54%, which changed the moving average for the period of 200-days by +18.93% in comparison to the 20-day moving average, which settled at $17.02. In addition, Sabra Healthcare REIT Inc saw -0.98% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 1,500 shares at the price of $15.92 back on Feb 24 ’25. After this action, Cusack Catherine now owns 60,583 shares of Sabra Healthcare REIT Inc, valued at $23,880 using the latest closing price.
Cusack Catherine, the Director of Sabra Healthcare REIT Inc, purchase 1,000 shares at $16.43 during a trade that took place back on Feb 21 ’25, which means that Cusack Catherine is holding 59,083 shares at $16,435 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.58 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.18. The total capital return value is set at 0.06. Equity return is now at value 4.57, with 2.37 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.18. The debt to equity ratio resting at 0.64. The interest coverage ratio of the stock is 1.69.
Currently, EBITDA for the company is 412.61 million with net debt to EBITDA at 3.97. When we switch over and look at the enterprise to sales, we see a ratio of 8.13. The receivables turnover for the company is 5.4for trailing twelve months and the total asset turnover is 0.13.
Conclusion
To wrap up, the performance of Sabra Healthcare REIT Inc (SBRA) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
